COULD A VACCINE ONE DAY BE GIVEN TO PREVENT BREAST CANCER AND OTHER FORMS OF THE DISEASE? MAYO CLINIC SURGEON DOCTOR AMY DEGNIM IS ON THE TEAM THAT’S EVALUATING A VACCINE AGAINST THE HER-2 PROTEIN FOUND IN THE MAJORITY OF WOMEN WITH NON INVASIVE BREAST CANCER CALLED DUCTAL CARCINOMA IN SITU, OR D-C-I-S
SHE ADDS THAT ASSESSING THIS VACCINE IN WOMEN WITH D-C-I-S IS AN IMPORTANT STEP TOWARD THE ULTIMATE GOAL OF ELIMINATING CANCER FROM OUR WORLD.
CLINICAL TRIALS AT THE MAYO CLINIC CONTINUE AND MAYO REPORTS PATIENTS CONTINUE TO SHOW POSITIVE RESULTS. A VACCINE COULD BE AVAILABLE WITHIN A COUPLE OF YEARS THAT MAY NOT ONLY STOP THE RECURRENCE OF BREAST AND OVARIAN CANCERS, BUT PREVENT THEM FROM DEVELOPING IN THE FIRST PLACE.
